"Drug Resistance, Fungal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation.
| Descriptor ID |
D025141
|
| MeSH Number(s) |
G06.225.383 G07.690.773.984.269.383
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Fungal".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Fungal".
This graph shows the total number of publications written about "Drug Resistance, Fungal" by people in this website by year, and whether "Drug Resistance, Fungal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 2 | 4 |
| 2003 | 1 | 3 | 4 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Fungal" by people in Profiles.
-
Mart?nez-Mat?as N, Rodr?guez-Medina JR. Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review. P R Health Sci J. 2018 09; 37(3):135-142.
-
Li QQ, Tsai HF, Mandal A, Walker BA, Noble JA, Fukuda Y, Bennett JE. Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida?glabrata under azole and hypoxic stress. Mol Med Rep. 2018 05; 17(5):6585-6597.
-
Camacho E, Chrissian C, Cordero RJB, Liporagi-Lopes L, Stark RE, Casadevall A. N-acetylglucosamine affects Cryptococcus neoformans cell-wall composition and melanin architecture. Microbiology (Reading). 2017 Nov; 163(11):1540-1556.
-
Vila TV, Chaturvedi AK, Rozental S, Lopez-Ribot JL. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. Antimicrob Agents Chemother. 2015 Dec; 59(12):7611-20.
-
Pierce CG, Srinivasan A, Ramasubramanian AK, L?pez-Ribot JL. From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms. Microbiol Spectr. 2015 Jun; 3(3).
-
Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, L?pez-Ribot JL. Antifungal therapy with an emphasis on biofilms. Curr Opin Pharmacol. 2013 Oct; 13(5):726-30.
-
Pierce CG, Lopez-Ribot JL. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov. 2013 Sep; 8(9):1117-26.
-
Hung CY, Wise HZ, Cole GT. Gene disruption in Coccidioides using hygromycin or phleomycin resistance markers. Methods Mol Biol. 2012; 845:131-47.
-
Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 2011 Sep; 7(9):e1002257.
-
Kim MS, Lee HM, Sung HS, Won CH, Chang SE, Lee MW, Choi JH, Moon KC. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy. Int J Dermatol. 2012 May; 51(5):621-3.